In chronic lymphocytic leukaemia (CLL), the most frequent JT breakpoint has been mapped to 17p11.2, with TP53 gene loss observed in 88% of cases either prior to or concurrent with JT formation [3]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.